-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA: APPROVES PEMBROLIZUMAB OR PEMBROLIZUMAB AND BERAHYALURONIDASE ALFA-PMPH EACH WITH ENFORTUMAB VEDOTIN-EJFV FOR MUSCLE INVASIVE BLADDER CANCER

Reuters·07/10/2026 14:26:38

Please log in to view news